ADAM17 INHIBITORS FOR USE IN THE PREVENTION AND/OR TREATMENT OF COVID-19

摘要

The invention relates to an ADAM17 inhibitor for use in the prevention and/or treatment of COVID-19 in a subject.;The invention further relates to a pharmaceutical composition comprising an ADAM17 inhibitor as an active ingredient for use in the prevention and/or treatment of COVID-19 in a subject.;The invention further relates to a kit of parts for use in the prevention and/or treatment of COVID-19 in a subject comprising i) an ADAM17 inhibitor and ii) a vaccine.;The invention further relates to a pharmaceutical composition comprising an ADAM17 inhibitor and an active immunization vaccine.;The invention further relates to a kit of parts comprising i) an ADAM17 inhibitor and ii) an active immunization vaccine.;The invention further relates to a method of preventing and/or treating COVID-19 in a subject, in the need thereof.